• Publications
  • Influence
Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient adults.
Hypopituitary patients have increased mortality from vascular disease, and in these patients, early markers of atherosclerosis [increased carotid artery intima-media thickness (IMT) and reducedExpand
  • 281
  • 6
Association of Vascular Endothelial Growth Factor Gene Polymorphism with Myocardial Infarction in Patients with Type 2 Diabetes
Background: Many studies have reported increased serum levels of vascular endothelial growth factor (VEGF) in patients with acute coronary syndromes. We searched for the association between eitherExpand
  • 53
  • 1
Reproducibility of the insulin tolerance test (ITT) for assessment of growth hormone and cortisol secretion in normal and hypopituitary adult men
OBJECTIVE The within subject variability of the insulin tolerance test (ITT) for assessment of growth hormone (GH) status and cortisol reserve has rarely been examined, particularly in patients withExpand
  • 67
Growth hormone (GH) and atherosclerosis: changes in morphology and function of major arteries during GH treatment.
Patients with hypopituitarism have increased carotid artery intima-media thickness and reduced arterial distensibility. The effect of 2 years of growth hormone (GH) replacement therapy on theseExpand
  • 27
Morphological and functional changes of the arterial wall in subjects at risk of atherosclerosis and in patients with peripheral arterial occlusive disease.
BACKGROUND The aim of this study was to determine the intima-media thickness (IMT) of the carotid arteries, which is regarded as the earliest morphological evidence of the atherosclerotic process inExpand
  • 20
Valves in the Heart of the Big Apple V: Evaluation and Management of Valvular Heart Diseases 2007.Third Annual Scientific Session: Heart Valve Society of America, New York City, N.Y., April 12–14,
s Cardiology 2007;107:444–456 445 LVH regression. Methods: 32 patients with compensated AS underwent CMR RF tagging to assess intramyocardial strain (HARP, Palo Alto, Calif., USA) of the endocardialExpand
Subject Index Vol. 107, 2007
Contents Vol. 107, 2007